Terms ending in 2043
Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,605,376 | Methods of Treating Relapsing Multiple Sclerosis Using an Inhibitor of Bruton's Tyrosine Kinase In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,497,430 | Methods of Producing Multimeric Proteins in Eukaryotic Host Cells In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,141,968 | Pathological Response Calculation and Assessment Tool In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,643,884 | 1-(2-(4-Cyclopropyl-1H-1,2,3-Triazol-1-YL)ACETYL)-4-Hydroxypyrrolidine-2-Carboxa|MIDE Derivatives as VHL Inhibitors for the Treatment of Anemia In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| US 12,731,251 | Multi Arm Machine Learning Models with Attention for Lesion Segmentation In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,071,422 | Process for Synthesis of Quinazoline Compounds In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,544,372 | Methods of Treating Rheumatoid Arthritis, Chronic Spontaneous Urticaria, and Systemic Lupus Erythematosis Using an Inhibitor of Bruton's Tyrosine Kinase In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| US 12,617,802 | Sulfonimidamide Compounds as NLRP3 Modulators In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,618,779 | Fluorescent Ellman Assay for Free Thiol Detection In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| US 12,676,015 | High Dimensional Spatial Analysis In force · High confidence | Genentech, Inc. | In force | High confidence | |
| 30 more term ends in 2043 · Pro | |||||
10 of 40 patents shown. Soonest term end first, then patent number.
Pro members see all 40.
37 of these are in force and held by Genentech, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.